Inventor · disambiguated record
Zachary K. Sweeney
Also filed as: SWEENEY ZACHARY · SWEENEY ZACHARY K · SWEENEY ZACHARY KEVIN
75 granted patents·22 pending applications·528 citations·filing 2004–2025
99Inventor score
Files withDENALI THERAPEUTICS INC39ROCHE PALO ALTO LLC17GENENTECH INC11NOVARTIS AG6CASTANEDO GEORGETTE4
Top patents by PatentIndex Score
97 records- 0197US11111235B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·7 cites·26 claims
- 0297US9896458B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·23 cites·6 claims
- 0397US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0496US9932325B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Apr 3, 2018·16 cites·30 claims
- 0595US7166738B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2005·Granted Jan 23, 2007·32 cites·19 claims
- 0694US9212173B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·18 cites·3 claims
- 0793US8815882B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsBAKER-GLENN CHARLES·Filed 2011·Granted Aug 26, 2014·34 cites·22 claims
- 0893US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0993US7906509B2Inhibitors of bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 15, 2011·26 cites·21 claims
- 1092US9212186B2Bicyclic pyrazole LRRK2 small molecule inhibitorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·11 cites·18 claims
- 1192US7189718B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Mar 13, 2007·33 cites·40 claims
- 1291US7683064B2Inhibitors of Bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 23, 2010·22 cites·19 claims
- 1391US7348345B2Nonnucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2007·Granted Mar 25, 2008·8 cites·7 claims
- 1491US7208509B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Apr 24, 2007·26 cites·33 claims
- 1590US11591316B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·1 cites·20 claims
- 1690US10590114B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·5 cites·27 claims
- 1790US8791130B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Jul 29, 2014·18 cites·21 claims
- 1889US9957290B2Derivatives of amphotericin BREVOLUTION MEDICINES INC·Filed 2016·Granted May 1, 2018·8 cites·18 claims
- 1989US9549916B2Isoxazole hydroxamic acid compounds as LpxC inhibitorsFU JIPING·Filed 2015·Granted Jan 24, 2017·10 cites·20 claims
- 2089US9145402B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Sep 29, 2015·15 cites·20 claims
- 2189US2025034119A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2288US9139566B2Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (PET) imaging for LRRK2GENENTECH INC·Filed 2012·Granted Sep 22, 2015·6 cites·12 claims
- 2388US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 2488US8796296B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 5, 2014·14 cites·21 claims
- 2586US10604535B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·3 cites·18 claims
- 2686US10131676B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·3 cites·33 claims
- 2786US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 2885US12358928B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·8 claims
- 2985US11834439B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·19 claims
- 3085US8394796B2Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of useCASTANEDO GEORGETTE·Filed 2012·Granted Mar 12, 2013·8 cites·20 claims
- 3185US8299077B2Inhibitors of Bruton's tyrosine kinaseBERTHEL STEVEN·Filed 2010·Granted Oct 30, 2012·19 cites·24 claims
- 3284US9814739B22′-ethynyl nucleoside derivatives for treatment of viral infectionsNOVARTIS AG·Filed 2016·Granted Nov 14, 2017·2 cites·10 claims
- 3384US2025388601A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3483US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 3583US10597420B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·20 claims
- 3683US8563540B2Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Oct 22, 2013·6 cites·9 claims
- 3783US8173650B2Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of useCASTANEDO GEORGETTE·Filed 2010·Granted May 8, 2012·7 cites·21 claims
- 3883US7666891B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Feb 23, 2010·6 cites·5 claims
- 3983US7625949B2Methods for treating retroviral infectionsROCHE PALO ALTO LLC·Filed 2005·Granted Dec 1, 2009·7 cites·13 claims
- 4081US8158625B2Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of useCASTANEDO GEORGETTE·Filed 2010·Granted Apr 17, 2012·6 cites·7 claims
- 4180US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 4280US10882883B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2020·Granted Jan 5, 2021·1 cites·24 claims
- 4380US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4479US9718792B2Isoxazoline hydroxamic acid derivatives as LpxC inhibitorsNOVARTIS AG·Filed 2017·Granted Aug 1, 2017·1 cites·16 claims
- 4579US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4678US8569281B2Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRKCHAN BRYAN K·Filed 2011·Granted Oct 29, 2013·9 cites·9 claims
- 4778US8440651B2Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2011·Granted May 14, 2013·4 cites·8 claims
- 4877US7754919B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Jul 13, 2010·2 cites·14 claims
- 4976US11028080B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·53 claims
- 5076US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zachary K. Sweeney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →